Add to ORKGTreatment options for prostatitis caused by multidrug-resis-tant gram-negative bacilli are limited. We report two cases cured with oral fosfomycin and provide a pharmacokinetic analysis of fosfomycin predose concentrations during treatment
textabstractFosfomycin has emerged as a potential therapy for multidrug-resistant bacterial infectio...
Fosfomycin (FOS) is a natural bactericidal broad-spectrum antibiotic which acts on proliferating bac...
Fosfomycin as an alternative therapeutic option for treatment of infections caused by multi-resistan...
Treatment options for prostatitis caused by multidrug-resistant gram-negative bacilli are limited. W...
The treatment of patients with prostatitis has been difficult due to the limitations of antibiotics ...
The problem of significantly reduced drug use concerns particularly the infections caused by multi-r...
Background. Multidrug-resistant gram-negative bacterial (MDR-GNB) infections of the prostate are an ...
Chronic bacterial prostatitis (CBP, NIH category II) is a diffi- cult-to-eradicate, recurring, chron...
This paper presents the results of a pilot study of difficult-to-treat patients (exhibiting several ...
AbstractFosfomycin is a broad-spectrum antibiotic discovered in Spain in 1969. It has bactericidal a...
Prostatitis is a clinical condition of difficult management and with limited antimicrobial options, ...
Urinary tract infections are one of the most common health problems and entail a high consumption of...
Fosfomycin has emerged as a potential therapy for multidrug-resistant bacterial infections. In most ...
Fosfomycin is a bactericidal, low-molecular weight, broad-spectrum antibiotic, with putative activit...
Fosfomycin is a broad-spectrum antibiotic which is established as therapy for uncomplicated lower ur...
textabstractFosfomycin has emerged as a potential therapy for multidrug-resistant bacterial infectio...
Fosfomycin (FOS) is a natural bactericidal broad-spectrum antibiotic which acts on proliferating bac...
Fosfomycin as an alternative therapeutic option for treatment of infections caused by multi-resistan...
Treatment options for prostatitis caused by multidrug-resistant gram-negative bacilli are limited. W...
The treatment of patients with prostatitis has been difficult due to the limitations of antibiotics ...
The problem of significantly reduced drug use concerns particularly the infections caused by multi-r...
Background. Multidrug-resistant gram-negative bacterial (MDR-GNB) infections of the prostate are an ...
Chronic bacterial prostatitis (CBP, NIH category II) is a diffi- cult-to-eradicate, recurring, chron...
This paper presents the results of a pilot study of difficult-to-treat patients (exhibiting several ...
AbstractFosfomycin is a broad-spectrum antibiotic discovered in Spain in 1969. It has bactericidal a...
Prostatitis is a clinical condition of difficult management and with limited antimicrobial options, ...
Urinary tract infections are one of the most common health problems and entail a high consumption of...
Fosfomycin has emerged as a potential therapy for multidrug-resistant bacterial infections. In most ...
Fosfomycin is a bactericidal, low-molecular weight, broad-spectrum antibiotic, with putative activit...
Fosfomycin is a broad-spectrum antibiotic which is established as therapy for uncomplicated lower ur...
textabstractFosfomycin has emerged as a potential therapy for multidrug-resistant bacterial infectio...
Fosfomycin (FOS) is a natural bactericidal broad-spectrum antibiotic which acts on proliferating bac...
Fosfomycin as an alternative therapeutic option for treatment of infections caused by multi-resistan...